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Introduction: Acute respiratory distress syndrome (ARDS) is a major cause of mortality in intensive care units. As
there is rising evidence about immuno-modulatory effects of lipid emulsions required for parenteral nutrition
of ARDS patients, we sought to investigate whether infusion of conventional soybean oil (SO)-based or fish oil
(FO)-based lipid emulsions rich in either n-6 or n-3 fatty acids, respectively, may influence subsequent pulmonary
inflammation.
Methods: In a randomized controlled, single-blinded pilot study, forty-two volunteers received SO, FO, or normal
saline for two days. Thereafter, volunteers inhaled pre-defined doses of lipopolysaccharide (LPS) followed by
bronchoalveolar lavage (BAL) 8 or 24 h later. In the murine model of LPS-induced lung injury a possible involvement of
resolvin E1 (RvE1) receptor ChemR23 was investigated. Wild-type and ChemR23 knockout mice were infused with both
lipid emulsions and challenged with LPS intratracheally.
Results: In volunteers receiving lipid emulsions, the fatty acid profile in the plasma and in isolated neutrophils and
monocytes was significantly changed. Adhesion of isolated monocytes to endothelial cells was enhanced after infusion
of SO and reduced by FO, however, no difference of infusion on an array of surface adhesion molecules was detected.
In neutrophils and monocytes, LPS-elicited generation of pro-inflammatory cytokines increased in the SO and
decreased in the FO group. LPS inhalation in volunteers evoked an increase in neutrophils in BAL fluids, which
decreased faster in the FO group. While TNF-α in the BAL was increased in the SO group, IL-8 decreased faster in
the FO group. In the murine model of lung injury, effects of FO similar to the volunteer group observed in wild-type
mice were abrogated in ChemR23 knockout mice.
Conclusions: After infusion of conventional lipid emulsions, leukocytes exhibited increased adhesive and
pro-inflammatory features. In contrast, FO-based lipid emulsions reduced monocyte adhesion, decreased
pro-inflammatory cytokines, and neutrophil recruitment into the alveolar space possibly mediated by ChemR23-signaling.
Lipid emulsions thus exert differential effects in human volunteers and mice in vivo.
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Acute respiratory distress syndrome (ARDS) is still linked
with a high mortality rate. Despite major advances in
intensive care medicine, a successful pharmacologic ap-
proach for the management of patients with ARDS is still
missing [1]. Pro-inflammatory mediators have been sug-
gested to contribute to primary and secondary organ dys-
function in experimental models of ARDS, and excessive
generation of these mediators has been observed in pa-
tients [2].
Monocytes have been suggested to be intimately in-
volved in controlling inflammatory cascades [3], as they
release both pro-and anti-inflammatory cytokines direct-
ing activation and recruitment of leukocyte populations,
such as polymorphonuclear granulocytes (PMN). The
PMN represent the first line of defense against invading
bacteria, yet they are capable of causing serious tissue
destruction [4].
Eicosanoids play an essential role in the modulation of
pro-inflammatory and anti-inflammatory events [5,6].
The n-6 fatty acids, including arachidonic acid, represent
the predominant polyunsaturated fatty acid in common
Western diets, and current nutritional regimes. Eicosa-
pentaenoic acid and docosahexaenoic acid are the most
important members of the n-3 family of fatty acids. Both
may serve as alternative lipid precursors for the cycloox-
ygenase and lipoxygenase pathways [6]. Moreover, by in-
corporation into various membrane (phospho)-lipid
pools, n-6 and n-3 fatty acids may affect lipid-signaling
events and may be mediated by the potent pro-
resolution lipid mediator class of resolvins [7,8].
Diets with specific fat composition may influence in-
flammatory and immunological events. Beneficial effects
of n-3 fatty acids have been demonstrated in experimen-
tal models of acute lung injury [9,10]. In patients with
lung injury or sepsis, an enteral diet enriched in n-3 fatty
acids and anti-oxidants reduced ventilation time, im-
proved the oxygenation index, and reduced the length of
stay in the intensive care unit [11]. However, recent
studies including a large multi-center trial conducted by
the ARDSnet (OMEGA) investigating the effect of an
enteral supplementation of n-3 fatty acids in ARDS pa-
tients revealed no beneficial effect [12,13]. The study
OMEGA was stopped early for futility, displaying a
higher rate of complications in the group receiving n-3
fatty acids. Due to the inconsistency of data on the en-
teral use of n-3 fatty acids in ARDS there is an ongoing
debate in the scientific community with a final recom-
mendation lacking at the moment. Data on the use of
n-3-based lipid emulsions in parenteral nutrition in
ARDS or even to reduce subsequent injury as currently
applied are scarce [14,15].
In the present study, we assessed the impact of two
commercially available lipid emulsions on isolatedleukocyte function and intra-alveolar recruitment of leu-
kocytes on subsequent endotoxin inhalation in healthy
volunteers. As recent studies suggest an involvement of
the novel n-3 derived lipid mediator resolvin E1 (RvE1)
and its receptor ChemR23 in the mediation of n-3-
induced (patho-)physiological effects, we additionally
subjected wild-type and ChemR23 knockout mice to a
model of experimental ARDS after infusion of lipid
emulsions.Material and methods
Study design
The University Ethics Committee (Ethikkommission des
Fachbereichs Medizin, Justus-Liebig University Giessen)
approved the study, and written informed consent was
obtained from each volunteer. The study was registered
as DRKS00006131 at the German Clinical Trial Registry.
Forty-two volunteers were recruited and blood was
drawn by venipuncture at 8 am of the first day. Via ante-
cubital venous access, a heparin infusion with 10,000
units/day was started for 48 h. Volunteers were then
randomized by closed envelopes into blocks of six to re-
ceive either 350 ml of a 10% fish oil (FO)-based lipid
emulsion (Omegaven®), a 10% soybean oil (SO)-based
lipid emulsion (Lipoven®), or NaCl 0.9% on both day 1
and day 2 (composition of the lipid emulsions is detailed
in Additional file 1: Table E1). Each infusion was started
at 4 pm and lasted for 12 h. At 4 h after completion of
the second infusion (8 am on the third day), the volun-
teers inhaled the endotoxin lipopolysaccharide (LPS).
After 8 or 24 h, blood was drawn by antecubital veni-
puncture and the volunteers underwent bronchoscopy
with bronchoalveolar lavage. Both volunteers and inves-
tigators performing the laboratory investigations were
blinded to the nature of lipid emulsion employed.Volunteer selection
The volunteers were >18 years of age, did not smoke,
and were not vegetarians. They did not take FO cap-
sules or any comparable nutritional supplementation.
Additional details are provided in the online data
supplement.LPS inhalation and bronchoalveolar lavage
The LPS inhalation was carried was carried out as de-
scribed by Kline et al. [16]. Further details are provided
in the online data supplement.Preparation of endothelial cells
Endothelial cells were obtained from human umbilical
veins according to Jaffe et al. [17].
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Human monocytes were isolated by density gradient
centrifugation, followed by counterflow centrifugation
elutriation [18].
Preparation of human granulocytes
Neutrophils were isolated by density gradient centrifuga-
tion [19].
Quantitative RT-PCR
Total RNA was extracted from freshly separated PMN,
subsequently reverse-transcribed and analyzed by quanti-
tative real-time PCR (PE Applied Biosystems, Wellesley,
MA, USA).
Monocyte adhesion and rolling assay
Monocyte adhesion and rolling were determined using a
parallel plate flow chamber [18].
Immunofluorescence analysis
Blood anticoagulated with EDTA was subjected to im-
munofluorescence [18]. Additional details are provided
in the online data supplement.
Culture and stimulation of monocytes and neutrophils
Monocytes or neutrophils (5 × 105 in a 24-well tissue cul-
ture plate) were cultivated and stimulated with vehicle
only (control) or 10 ng/ml LPS for 24 h at 37°C, 5% CO2.
Measurement of cytokines (TNF-α, IL-1β, IL-8, IL-10)
was performed in cell culture supernatant using commer-
cially available ELISA Kits (R&D Systems, Wiesbaden,
Germany) according to the manufacturer’s instructions.
Analysis of fatty acids
Analysis of cellular lipids and free fatty acids was per-
formed by means of gas chromatography [18].
Animals and experimental lung injury protocol
Local government authorities and university officials
responsible for animal protection approved the study (Justus-
Liebig University Giessen, Regierungspraesidium Giessen).
The murine model of long-term infusion and subsequent
acute lung injury has been previously described [20]. Wild-
type (Sv129/S1) and ChemR23−/− mice [21] were used for
experiments. After implantation of a jugular vein catheter
a subsequent adaptation to an osmotic mini-pump (Alzet,
Cupertino, CA, USA) was performed. Seven days after
central venous catheter implantation in mice, continuous
infusion (6.5 μl/h) of either 10% FO-based lipid emulsion
(Omegaven®, Fresenius Kabi, Bad Homburg, Germany),
10% SO-based lipid emulsion (Lipoven®, Fresenius Kabi,
Bad Homburg, Germany), or NaCl 0.9% was performed
with the mice being allowed access to water and chow
ad libitum. The amount of lipids infused is equivalentto 1.0 g/kg/d. However, energy expenditure of mice is
nearly three times higher compared to humans. Therefore,
the infused lipids were considered to be close to the lower
limits of the recommended amount of lipids in parenteral
nutrition. While receiving infusions, mice were subcutane-
ously injected with a low dose of unfractionated heparin.
Thereafter, anesthetized mice were instilled with LPS
(0 or 1 μg in 200 μl normal saline/mouse): 8 or 24 h after
LPS application, mice were sacrificed by an overdose of
anesthesia, and bronchoalveolar lavage was performed.
Statistical analysis
Data are provided as the mean ± standard error of the
mean (SEM). Two-way analysis of variance (ANOVA)
was used to test for differences between time points
(baseline, 8 h, and 24 h) and infusion groups (NaCl, SO,
FO). Post hoc analysis was carried out using the Student-
Newman-Keul test. If data were not normally distrib-
uted, logarithmic transformation was performed. In the
case of bronchoalveolar lavage, two-way ANOVA across
time points (8 and 24 h) and between infusion groups
(NaCl, SO, FO) was used for comparison. A P-value
<0.05 was considered to indicate statistical significance.
Results
Clinical course
All volunteers but one received a complete infusion
course of FO-based lipid emulsions, SO-based lipid
emulsions, or NaCl in a randomized fashion (Additional
file 1: Figure E1). During the infusion periods, no ad-
verse events occurred. All infusions were well-tolerated,
no overt bleeding was noted, and the volunteers did not
report problems concerning with the infusion site. After
LPS inhalation, most volunteers reported chill, fatigue,
and coughing but the symptoms resolved within 6 h.
Leukocyte invasion after LPS-inhalation
Recovery of the 150-ml normal saline instilled for lavage
did not differ significantly between the groups. In a
historical control group of healthy volunteers, we found
9.5 ± 1.3 × 106 leukocytes and 0.3 ± 0.1 × 106 PMN in
bronchoalveolar lavage fluid (BALF). In volunteers re-
ceiving NaCl-infusions, 72.6 ± 17.2 × 106 leukocytes
were detected in the BALF 8 h after LPS inhalation with
a predominant neutrophil population of 35.7 ± 8.3 × 106
cells (Figure 1a). Macrophages and monocytes accounted
for 9.1 ± 2.7% and lymphocytes for 41.3 ± 4.2% of the
leukocytes (Additional file 1: Figure E2). Leukocytes fur-
ther increased 24 h after inhalation showing a neutrophil
predominance again. Infusion of SO-based lipid emul-
sions induced leukocyte counts in BALF similar to those
in the NaCl group 8 and 24 h after LPS inhalation. Vol-
unteers receiving FO-based lipid emulsions displayed
similar leukocyte counts compared to the other groups
Figure 1 Impact of infusions on leukocytes and cytokines in the
bronchiolar lavage fluid (BALF) after lipopolysaccharide (LPS)-inhalation.
BAL was performed 8 or 24 h after LPS inhalation in volunteers
undergoing infusion of soybean-based lipid emulsions (SO), fish
oil-based lipid emulsions (FO), or normal saline (NaCl). For comparison,
a cohort of healthy volunteers (historical controls) is depicted. Total
leukocytes (a), TNF-α (b), and IL-8 (c) were determined in the BALF:
24 h after LPS challenge lower leukocyte numbers were detected in
the FO group (*P <0.05 versus both other groups). TNF-α was increased
in the SO group at 8 h but was similar to the other infusion groups at
24 h (*P <0.05 versus both other groups; aP <0.05 versus 24 h). Lowest
IL-8 concentrations were determined in the FO group at 24 h (*P <0.05
versus both other groups; aP <0.05 versus 8 h). Data are given as
mean +/− standard error of the mean; n = 5 to 6 experiments each.
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group was a decrease in leukocytes in BALF after 24 h,
as leukocytes and neutrophils differed significantly from
both other groups at this time point (P <0.05). The leu-
kocyte differentiation pattern did not differ significantly
between the groups at either time point.
TNF-α and IL-8 in bronchoalveolar lavage fluid (BALF)
We then determined cytokines in the BALF to gain
insight into inflammatory activation after LPS inhalation.
In our historical control group of healthy volunteers,
concentrations of TNF-α and IL-8 were close to the de-
tection limit. In the NaCl-group, TNF-α concentration
in BALF (Figure 1b) increased 8 and 24 h after LPS-
inhalation, respectively, and was comparable to the con-
centrations determined in the group receiving FO-based
lipid emulsions. After infusion of SO-based lipid emul-
sions, TNF-α concentrations were more markedly in-
creased in BALF 8 h after LPS inhalation, and differed
significantly from both other groups (P <0.05). Levels of
TNF-α in BALF were lower in all groups at 24 h com-
pared to their respective 8 h concentrations but the de-
crease was only significant for the n-6 group (P <0.05).
The IL-8 concentrations increased in the NaCl group
8 h after LPS inhalation and remained elevated at 24 h
(Figure 1c). While IL-8 concentrations were nearly
identical in volunteers receiving SO-based lipid emul-
sions, they were 43% higher in the FO group at 8 h
compared to the NaCl group and significantly lower
at 24 h, differing at this time point from both other
groups (P <0.05).
IL-8 generation in isolated neutrophils
As the next step, we investigated the effect of lipid emul-
sion and LPS inhalation on the cytokine release of PMN
isolated from blood. Before LPS inhalation and infusion,
IL-8 generation in neutrophils elicited by 10 ng/ml LPS
was 3,515 ± 530 pg/ml in the NaCl group (Figure 2a).
The IL-8 secretion decreased to 66% at 8 h and to 88%
at 24 h after LPS inhalation in this group. In the FO
Figure 2 Impact of infusions on leukocyte cytokine release. Polymorphonuclear cells (PMN) (a, b) or monocytes (c-f) originated from
volunteers receiving fish oil-based (FO) or soybean oil-based (SO) lipid emulsions, or normal saline (NaCl). RNA was extracted from PMN (b);
quantitative PCR was performed and ΔΔCt values were calculated (see methods). Leukocytes were stimulated with lipopolysaccharide (LPS)
and cytokine release was assessed after 24 h. Expression (b) of IL-8 and TNF-α were reduced in the FO group as compared to the SO and
NaCl (*P <0.05) and NaCl groups (aP <0.05), respectively). Generation of IL-8 by PMN (a) was increased in the SO group but reduced in the FO
group (*P <0.05 versus baseline; aP <0.05 versus SO and NaCl; bP <0.05 versus 8 h; cP <0.05 versus NaCl). TNF-α in monocytes (c) was reduced
in the FO group (*P <0.05 versus baseline and 8 h; bP <0.05 versus SO and NaCl). IL-1 (d) also decreased in the FO group (bP <0.05 versus
NaCl; aP <0.05 versus NaCl and SO; *P <0.05 versus baseline). In contrast, IL-8 synthesis (e) in the FO group did only differ at 8 h from the NaCl
group (*P <0.05). IL-10 (f) was decreased in a similar manner in the FO group (*P <0.05 versus baseline; aP <0.05 versus NaCl and SO). Data are
given as mean ± standard error of the mean; n = 12 (baseline) or 5 to 6 (post-inhalation) experiments each. Error bars are not evident when
obscured by the symbol.
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3,659 ± 353 pg/ml before inhalation to 38% and 44%,
at 8 and 24 h, respectively, after LPS inhalation (P <0.05, 8
and 24 h versus baseline). In the SO group, generation of
IL-8 also decreased to 72% 8 h after LPS inhalation. In
contrast to the NaCl and the FO groups, IL-8 synthesis
increased to 6,277 ± 1276 pg/ml at 24 h in the SO group
(P <0.05 versus FO and versus baseline).TNF-α, CD18 and IL-8 gene expression in PMN
To assess the gene expression of TNF-α, CD18 and IL-8,
PMN were isolated from the blood 24 h after LPS inhal-
ation and subjected to quantitative RT-PCR (Figure 2b).
The ΔΔCt values were calculated comparing gene ex-
pression (normalized to a housekeeping gene) of the dif-
ferent treatment groups to their corresponding values
before treatment. In the group receiving FO-based lipids,
Figure 3 Impact of infusions on monocyte rolling and adhesion
to a human endothelial monolayer after LPS inhalation. Isolated
monocytes originated from volunteers receiving fish oil (FO)- or
soybean oil (SO)-based lipid infusion, or normal saline (NaCl).
Adhesion (a) and rolling (b) were investigated on TNF-α-activated
endothelial cells under laminar flow conditions (mean ± standard
error of the mean; n = 12 for baseline and 5 to 6 for post-inhalation
experiments). Adhesion was significantly different 8 h after inhalation
between all groups (aFO versus SO, P <0.01; bNaCl versus FO or SO,
P <0.05. The increased adhesion in the SO group was significantly
different from its baseline and 24-h values (cP <0.05 for each
comparison). At 8 h post-inhalation, adhesion in the FO group was
lower as compared to its baseline (*P <0.05). Rolling was reduced in
all infusion groups 8 h after LPS inhalation and the reduction was
significant in the NaCl and FO groups (aP <0.05; *P <0.01 versus
respective baseline and P <0.05 versus 24 h). Rolling at 8 h was lower
in monocytes isolated after FO infusion as compared to both other
groups (bP <0.01 versus SO and P <0.05 versus NaCl).
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IL-8 compared to volunteers receiving SO-based lipid
emulsions and the NaCl group (P <0.05). The TNF-α
expression was furthermore decreased in the FO group
(P <0.05), whereas the group infused with SO-based
lipid emulsion did not reduce TNF-α levels significantly.
Expression of CD18 did not differ significantly among
the groups tested.
Generation of TNF-α, IL-1β, IL-8, and IL-10 in isolated
monocytes
Before LPS inhalation and infusion, generation of TNF-α
in isolated monocytes stimulated with 10 ng/ml LPS was
1,752 ± 359 pg/ml in the group receiving NaCl and
did not differ significantly between infusion groups
(Figure 2c). In the groups infused with NaCl and SO
TNF-α synthesis increased 8 h after LPS inhalation
and returned to pre-inhalation levels after 24 h. In
volunteers receiving FO-based lipid emulsions, TNF-α
synthesis was significantly reduced 24 h after LPS inhal-
ation (P <0.05; 24 h versus baseline).
Baseline synthesis of IL-1β in isolated monocytes
challenged with 10 ng/ml LPS in the control group
was 2,973 ± 548 pg/ml (Figure 2d) increasing 8 h and
24 h after LPS inhalation. In the SO group, IL-1β
synthesis exhibited a similar pattern, whereas in the
group receiving FO-based lipid emulsions, IL-1β synthesis
decreased 8 h and 24 h after inhalative LPS challenge.
The IL-1β generation 24 h after LPS-challenge in the
FO group differed significantly from its baseline and
from the NaCl group (P <0.05 for each comparison).
The baseline LPS-induced generation of IL-8 was
3,13.1 ± 50.0 ng/ml in the NaCl group and neither of
the other groups differed significantly at this time point
(Figure 2e). The IL-8 synthesis peaked 8 h after LPS in-
halation and returned to baseline after 24 h in the NaCl
group but the time points did not differ significantly
from baseline. While the SO group displayed a similar
pattern, a consistent reduction in IL-8 generation
after LPS inhalation in the FO group was observed,
which differed significantly from the NaCl group at 8
h (P < 0.05).
Last, the LPS-induced synthesis of the anti-inflammatory
cytokine IL-10 in isolated monocytes was examined
(Figure 2f ). Baseline generation determined in the
NaCl group was 2,838 ± 364 pg/ml and the volun-
teers in both lipid groups displayed similar values.
The IL-10 synthesis was not significantly affected by
LPS inhalation and infusion in the NaCl and SO
groups. In contrast, after infusion of FO-based lipid
emulsions and LPS-challenge we found a significant
reduction of IL-10 generation (P <0.05, FO versus both
other groups and baseline versus both post-inhalation
time points).Adhesion and rolling
We then determined if lipid emulsions and LPS inhal-
ation changed the adhesive properties of monocytes
using a parallel flow chamber (Figure 3). Before infusion
and inhalation, 73.6 ± 6.6 monocytes were adherent in
the NaCl group, a feature unchanged at 8 and 24 h after
inhalation. Eight hours after LPS inhalation, the number
of adherent monocytes was reduced in the FO group but
increased in the SO group. All groups differed signifi-
cantly at this time point (P <0.05). After 24 h, the num-
ber of adherent monocytes reached pre-infusion values
Table 1 Fatty acids in the plasma and monocyte
membranes
Time, hours
Group 0 8 24
Free fatty acid,
μmol/l
AA NaCl 4.0 ± 0.6 3.3 ± 0.3 4.9 ± 1.0
SO 4.0 ± 0.6 4.0 ± 0.7 4.6 ± 1.3
FO 4.3 ± 0.5 4.2 ± 0.8 5.0 ± 1.1
EPA NaCl 0.6 ± 0.1 0.3 ± 0.0 0.4 ± 0.1
SO 0.6 ± 0.1 0.5 ± 0.1 0.7 ± 0.2
FO 0.7 ± 0.2 3.4 ± 0.8ab 2.5 ± 0.4ab
DHA NaCl 0.8 ± 0.1 0.6± 0.2 0.9 ± 0.2
SO 0.8 ± 0.1 0.9 ± 0.1 1.0 ± 0.2
FO 0.9 ± 0.1 2.2 ± 0.3a b 3.0 ± 0.7a b
Sum NaCl 335.1 ± 50.2 336.8 ± 42.4 408.6 ± 74.3
SO 346.0 ± 53.9 372.1 ± 42.1 366.5 ± 59.8
FO 377.4 ± 44.1 250.1 ± 29.8 348.3 ± 83.0
Membrane fatty
acid. %
AA NaCl 19.7 ± 0.5 19.2 ± 0.6 18.5 ± 0.5
SO 19.4 ± 0.4 18.0 ± 0.8 20.0 ± 0.3
FO 19.4 ± 0.6 17.1 ± 0.8a 17.4 ± 1.1a
EPA NaCl 0.2 ± 0.0 0.1 ± 0.0 0.1 ± 0.0
SO 0.2 ± 0.0 0.1 ± 0.0 0.2 ± 0.0
FO 0.2 ± 0.0 1.9 ± 0.2a b 1.3 ± 0.1a b
DHA NaCl 2.6 ± 0.1 2.4 ± 0.3 2.3 ± 0.2
SO 2.9 ± 0.2 2.5 ± 0.3 2.8 ± 0.4
FO 3.1 ± 0.2 4.8 ± 0.2a b 4.7 ± 0.4a b
Plasma and isolated monocytes originated from volunteers receiving fish oil (FO)-
or soybean oil (SO)-based lipid infusion, or normal saline (NaCl). Free fatty acids
(AA, arachidonic acid; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid)
and membrane fatty acids were determined by gas chromatography: aP <0.05
versus baseline; bP <0.05 versus SO and NaCl. Data are presented as mean +/-
standard error of the mean; n =12 for baseline and n = 5 – 6 for later time points.
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FO group at 8 h differed significantly from its baseline
while the SO group at 8 h was significantly different
from both other time points.
Under baseline conditions, similar numbers of mono-
cytes were rolling in the NaCl, FO, and SO group. Eight
hours after infusion and LPS inhalation, the number of
rolling monocytes dropped to 46% in the NaCl group
but decreased only slightly in the SO group. The number
of rolling monocytes were significantly reduced to 25%
in the FO group (P <0.05, baseline versus 8 h post-
inhalation) differing significantly from both other groups
(P <0.05). At 24 h after inhalation, rolling monocytes in-
creased in the NaCl and FO groups (P <0.05 versus 8 h).
Flow-cytometric analysis in monocytes and PMN
Next we sought to examine if the changes in rolling and
adhesion were mirrored in alterations of surface adhe-
sion molecules. Monocytes and PMN were examined for
changes in expression of adhesion molecules CD11b
(Mac-2), CD14, CD18, CD45, CD49d (VLA-4), CD62L
(L-selecin), CD162 (P-selectin glycosylated ligand (PSGL)-1),
and CC-chemokine receptor 2 (CCR2) and CCR5 by flow
cytometry (Additional file 1: Table E2 + E3). Two-way
ANOVA of monocytes revealed time-dependent effects if
all groups were pooled, which became significant only in
part in the individual treatment groups. The CD11b ex-
hibited a significant time-dependent response, with ex-
pression peaking at 8 h (P <0.01) but was only significant
in the FO and SO group. A similar pattern was observed
for CD18, which was upregulated after 8 h in all groups.
Only the FO group was significantly different from base-
line. Expression of CD49d in the pooled groups was de-
creased at 8 h, and significantly increased values at 24 h,
but only the SO group differed significantly at 24 h com-
pared to the 8-h values. Interestingly, we could not reveal
any inter-group difference for any surface molecules ex-
amined despite significant changes in the adhesive proper-
ties in the cell assay.
In neutrophils, a significantly lower expression of
CD11b 24 h after LPS challenge (P <0.05 versus baseline
and versus 8 h) was detected in all infusion groups. The
CD14 exhibited increased expression in all groups, both
8 and 24 h after LPS stimulation, compared to baseline.
Expression of all the other markers tested displayed no
significant changes comparing pre-infusion to post-
inhalation values within one infusion group. In addition,
no significant differences were found between infusion
groups.
Plasma free fatty acids
The sum of all free fatty acids in plasma in the NaCl
group before the start of infusions was 335.1 ± 50.2
μmol/l (Table 1). Levels did not change significantly 8 or24 h after inhalation with both other groups exhibiting
the same pattern. Free arachidonic acid levels were
determined as 4.0 ± 0.6 μmol/l at baseline in the NaCl
group (Table 1). No significant differences in levels were
determined between the different groups and after inhal-
ation with each group. For both n-3 fatty acids, no
significant differences in fatty acid concentrations were
found at baseline between the infusion groups (Table 1).
While concentrations in the NaCl and SO groups
remained stable, eicosapentaenoic acid levels rose in the
group receiving FO-based emulsions 8 h and 24 h after
LPS inhalation. An increase was also found in levels of
docosahexaenoic acid, peaking at 24 h. At 8 and 24 h,
both fatty acids differed significantly from baseline and
from concentrations in the NaCl and SO group (P <0.05
for each comparison.
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As fatty acid composition of the cell membrane may in-
fluence intracellular signal transduction we determined
the fatty acid profile of monocytes isolated from blood.
Baseline arachidonic acid content in monocytes was
19.70 ± 0.45% of all fatty acids in the NaCl group and
was slightly reduced after LPS inhalation (Table 1). In
the FO group, arachidonic acid content was reduced,
and differed significantly from baseline (P <0.05 at 8 h
and 24 h versus baseline). In the FO group, eicosapenta-
enoic acid and docosahexaenoic acid increased markedly
8 h and 24 h, respectively, after LPS inhalation (Table 1).
Levels of both fatty acids differed significantly from
baseline values, and from the other infusion groups at
these time points. The ratio of arachidonic acid: (eicosa-
pentaenoic acid + docosahexaenoic acid) did not signifi-
cantly change in the NaCl and SO groups. However, it
was 6.4:1 at baseline, and was decreased at 8 or 24 h in
the n-3 group (2.6: 1 and 2.9:1; P <0.05 versus baseline
and between groups).
Membrane fatty acid profile in neutrophils
A similar pattern compared to the free fatty acids was
detected in the membrane lipids of PMN (Additional
file 1: Figure E3). Baseline arachidonic acid content was
9.00 ± 0.20% of all fatty acids in the NaCl group, and
was similar in all groups and all time points. In the FO
group, eicosapentaenoic acid increased about three to
four times 8 h and 24 h after LPS inhalation. Docosa-
hexaenoic acid levels rose from 0.55 ± 0.05% to 0.75 ±
0.11% and 0.79 ± 0.10%. Both fatty acids differed signifi-
cantly from baseline and between the groups at these
time points. The ratio of arachidonic acid:(eicosapentae-
noic acid + docosahexaenoic acid) did not change in the
NaCl and SO groups. However, this ratio was 14.5:1 at
baseline, and dropped significantly at 8 or 24 h in the
FO group (6.5:1 and 7.1:1; P <0.05 versus baseline and
between groups).
Chemerin receptor 23 (ChemR23) in experimental acute
lung injury
To elucidate potential underlying mechanisms involved
in the beneficial role of FO in ARDS we used the murine
model of LPS-induced acute lung injury (ALI). LPS-
instillation increased alveolar recruitment of leukocytes
8 and 24 h after induction of ALI in wild-type (WT) ani-
mals (Figure 4a). After 8 h, FO-infused WT mice dis-
played a significant decrease in alveolar leukocyte counts
as compared to NaCl-treated animals (P <0.05), whereas
SO-infused mice displayed the highest values compared
to FO and NaCl (P <0.05). The beneficial effect of FO in-
fusion was diminished in ChemR23−/− as these animals
showed significantly increased alveolar leukocyte inva-
sion compared to WT (P <0.05). A similar pattern wasobserved 24 h after LPS instillation as mice infused with
FO displayed the lowest leukocytes counts compared
to NaCl and SO (P <0.05). Also at this time-point,
ChemR23−/− mice of the NaCl and FO group revealed
significantly elevated alveolar leukocytes compared to the
respective WTgroups (P <0.05).
Next, we investigated LPS-induced protein extravasa-
tion in ALI (Figure 4b). Despite an increase in protein
concentration both at baseline (0 h) and after 8 h no sig-
nificant changes occurred among the different groups.
At 24 h after LPS challenge, WT animals infused with
FO exhibited the lowest protein levels in the BALF com-
pared to NaCl and SO (P <0.05), whereas this effect was
abrogated in ChemR23−/− mice. In addition, we observed
significantly increased protein leakage in ChemR23−/−
mice infused with NaCl or FO compared to the respective
WT controls (P <0.05). Finally, we sought to assess the
concentration of the pro-inflammatory cytokine, macro-
phage inflammatory protein (MIP)-2 in BALF (Figure 4c).
Consistent with the above mentioned results, MIP-2 levels
8 h after LPS challenge were significantly elevated in
ChemR23−/− mice infused with NaCl or FO compared
with the respective WT animals (P <0.05). After 24 h, the
lowest MIP-2 levels were detected in the FO group of WT
mice compared to NaCl and SO, whereas this observation
was diminished in ChemR23−/− animals (P <0.05).
Discussion
In the present study, a distinct and differential impact of
SO- versus FO-based lipid emulsions on key leukocyte
features was detected in healthy volunteers after an infu-
sion period of 48 h and subsequent LPS inhalation. The
fish oil (FO)-based lipid preparation shifted the n-3/n-6
ratio of plasma free fatty acids from an n-6 predomin-
ance to an n-3/n-6 balance, reduced ex vivo leukocyte
pro-inflammatory cytokine generation, decreased iso-
lated monocyte rolling and adhesion to endothelial cells,
and decreased the number of PMN recruited into the
bronchoalveolar compartment. In contrast, monocyte
adhesion, neutrophil cytokine generation, and tumor-
necrosis factor-α concentration in BALF were markedly
enhanced by the standard SO-based lipid emulsion.
These observed effects of FO-based lipid emulsions
might at least in part be mediated by resolvin receptor
ChemR23.
Invasion of leukocytes into the alveolar space
Neutrophil invasion into the alveolar space after LPS
challenge is a well-documented response in mice and
men [16,22]. In mice, sequestration of neutrophils in the
pulmonary capillaries takes place within one hour, trans-
endothelial migration reaches a plateau between 12 and
24 h, and trans-epithelial migration peaks after 24 h
[22]. In all volunteers, a massive increase in leukocytes
Figure 4 Chemerin receptor 23 (ChemR23) in experimental acute lung injury (ALI). Wild-type (WT) and ChemR23 knockout (ChemR23−/−) mice
received infusions with NaCl, fish-oil (FO)- or soybean oil (SO)-based lipid emulsions and were subjected to lipopolysaccharide (LPS) for the
indicated time points. (a) WT mice receiving FO displayed the lowest leukocytes in their bronchiolar lavage fluid (BALF) at 8 h compared to NaCl
(*P <0.05 versus NaCl), whereas the SO group had the highest values (aP <0.05 versus FO and NaCl). The effect of FO-treatment was diminished
in ChemR23−/− showing significantly increased alveolar leukocyte invasion compared to WT (bP <0.05). After 24 h, the WT-FO group displayed
lowest leukocytes counts (cP <0.05 versus NaCl and SO). At this time point, ChemR23−/− mice of the NaCl and FO group revealed significantly
elevated alveolar leukocytes compared to the respective WT (dP <0.05). (b) Protein extravasation 24 h after LPS challenge in WT animals infused
with FO was lowest compared to NaCl and SO (*P <0.05), whereas ChemR23−/− mice showed significantly increased protein leakage in mice
infused with NaCl or FO compared to the respective WT controls (bP <0.05). (c) Macrophage inflammatory protein (MIP)-2 levels 8 h after LPS
challenge were significantly elevated in ChemR23−/− mice infused with NaCl or FO compared with the respective WT animals (aP <0.05). After
24 h the lowest MIP-2 levels were detected in the FO group of WT mice compared to NaCl and SO (*P <0.05).
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LPS inhalation was noted. The number of leukocytes (70
to 80 million) needs to be compared to 9.5 × 106 leuko-
cytes found in BALF from a historical cohort of volun-
teers at our institution who were not exposed to LPS
[23]. In volunteers receiving NaCl or SO-based lipid
emulsions, leukocytes and neutrophils were even moreincreased after 24 h, which is well in line with kinetics in
the murine model. In contrast, in volunteers with pre-
infusion of FO-based lipids leukocytes and neutrophils
were significantly decreased 24 h after LPS inhalation.
This may be interpreted as reduced or shortened influx
of neutrophils invading the alveolar space due to reduced
cytokine generation and decreased adhesive properties. It
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the time-frame for transmigration of neutrophils. Alter-
natively, resolvins, which are exclusively metabolized from
eicosapentaenoic acid or docosahexaenoic acid, were shown
to lead to a faster resolution of the allergic airway inflam-
mation and may influence leukocyte kinetics [24]. Gener-
ation of these novel mediators may have fastened the
resolution of the LPS-induced inflammation and increased
the resolution of inflammatory response.
Rolling and adhesion of monocytes
Monocytes adhere spontaneously to endothelial cell
monolayers using a static assay, but substantial monocyte-
endothelial adhesion under flow conditions demands pre-
ceding cytokine stimulation of the endothelial cells: E-
selectin-L-selectin, ICAM-1-β2 integrin and in particular
VCAM-1-VLA-4- interactions were shown to represent
predominant adhesive forces under these conditions [25].
The finding of increased adhesive features after applica-
tion of SO and reduced adhesion and rolling after infusion
of FO-based lipids is corroborated by our previous study
showing a similar effect of lipid emulsions in volunteers
without LPS inhalation [18]. The marked change of endo-
thelial adhesion and rolling of monocytes isolated after in-
fusion of lipid emulsions might be mirrored in monocyte
adhesion molecules. However, no major differences in
expression of adhesion molecules between infusion groups
were noted. This confirms previous data obtained from
healthy volunteers undergoing infusion of lipid emulsions
without LPS challenge [18]. However, the findings are in
contrast to the observation that supplementation of the
diet of healthy volunteers with 3 g FO per day for three
weeks resulted in a significant reduction in the expression
of ICAM-1 and CD11a on both freshly prepared and
interferon-stimulated peripheral blood monocytes [26].
Interestingly, an effect of LPS inhalation on the upregula-
tion of CC11b and CD18 was detected 8 h after LPS inhal-
ation in all groups irrespective of infusion regimen. This
upregulation contrasts with the finding of a reduced ex-
pression of CD11b in monocytes after LPS inhalation in
asthmatic subjects [27] but differences in timing of the
analysis and dose of inhaled LPS may account for the
difference.
Irrespective of the common trend of increased expres-
sion of CD11b and CD18 in all groups 8 h after inhal-
ation, rolling and adhesion differed between the infusion
groups. It is speculated that changes in membrane lipid
composition as mirrored by the n-3: n-6-ratio may be at
least in part responsible for the difference. As rolling
and adhesion of monocytes require cross-talk between
the activated endothelium and monocytes, reduced
intracellular and intercellular signal transduction after
infusion of FO-derived lipids may translate into a decrease
in adhesive properties of monocytes. Second messengerpathways include generation of inositol phosphates with a
known reduction of these products in leukocytes after in-
gestion of fish oil capsules [28]. However, generation of
inositolphosphates is only one part of a major network
of signal transduction pathways (for example, phospha-
tidylinositol-3 kinase, diacylglycerol, membrane rafts, and
phospholipase A2) being dependent on membrane lipids
and modulated by their change [7,29]. These pathways
and their actions are referred to as lipid signaling. A
change in these lipid-dependent pathways may also ac-
count for a possible impact of SO- and FO-derived
lipids on a change in avidity of integrins. However, it
cannot be fully excluded that further adhesion mole-
cules are responsible for the difference in rolling and
adhesion of monocytes, such as chemokines of the GRO
family [30], which were not determined in the present
study.
Changes in fatty acid profile
A rapid and sustained increase in free eicosapentaenoic
acid and docosahexaenoic acid concentration was noted
after infusion of FO-based lipids, counterbalancing ara-
chidonic acid. The arachidonic acid:(eicosapentaenoinc
acid + docosahexaenoic acid) quotient in this compart-
ment shifted from n-6 predominance to an n-3:n-6-
equivalence within 48 h of infusion therapy. This prompt
appearance of free n-3 fatty acids indicated rapid hy-
drolysis of n-3 fatty acid-containing triglycerides sup-
plied by the lipid emulsion. The rapid rate of appearance
of free n-3 fatty acids exceeds corresponding alterations
in response to conventional dietary FO uptake by order
of magnitude [31]. The changes in plasma fatty acid pro-
file are paralleled by an increase in n-3 fatty acids in
the membranes of leukocytes. In fact, a significant in-
crease in the n-3:n-6 fatty acid ratio in the monocyte
and neutrophil membrane lipid pool was noted; how-
ever, within the short infusion time and high percent-
age of arachidonic acid in the membranes the changes
were not as dramatic as in the plasma free fatty acid
fraction.
Cytokine generation in isolated monocytes and neutrophils
No significant difference in cytokine generation of the
isolated blood leukocytes before and after LPS inhalation
in the NaCl group was detected. It is possible that
the absence of an LPS effect on circulating leukocytes
is due to largely compartmentalized inflammation in
the alveolar space. However, this idea is not supported by
the upregulation of CD11b and CD18 on monocytes after
LPS inhalation. On the other side, leukocytes activated
due to the LPS challenge may sequester in the lung ca-
pillaries and transmigrate. The remaining circulating
leukocytes assessed for this study may be a non-activated
population.
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kines TNF-α, IL-1, and IL-8 in monocytes and IL-8 in
neutrophils induced by LPS was significantly reduced
after infusion of FO-based lipid emulsions. In contrast,
increased synthesis in IL-8 in neutrophils was noted in
the SO group. A reduction in the generation of TNF-α
after long-term dietary intake of FO capsules was first
described by Endres et al. [32] and confirmed after infu-
sion of FO-derived lipids [18,33]. However, the under-
lying mechanisms are not fully understood. As discussed
for the adhesive properties, enrichment of membrane n-3
fatty acids may have a modulating effect on second
messenger pathways. In addition, generation of eicosa-
pentaenoic acid-derived eicosanoids such as leukotriene
(LT)B5 and thromboxane (Tx)A3 has been demonstrated
after infusion of FO-based lipid emulsions [34]. Such a
shift might interfere with eicosanoid-dependent auto-
amplification loops, as described for the regulation of
TNF-α-synthesis in monocytes by TxA2 [35].
Inflammatory cytokines in bronchoalveolar lavage fluid
Several groups have used bronchoscopy in healthy vol-
unteers to investigate the impact of inhalation of LPS or
LPS challenge on local inflammatory responses in the
alveolar compartment, which is mirrored by invasion of
neutrophils, and an increase in pro-inflammatory cyto-
kines in the BALF, [36,37]. In the BALF, a marked in-
crease in TNF-α and in IL-8 was noted after LPS
inhalation when compared to cytokine concentrations
determined as being close to the detection limit in group
of unexposed healthy volunteers [23]. After LPS inhal-
ation, TNF-α concentration was elevated at 8 h and fell
after 24 h in all infusion groups. The IL-8 concentrations
8 and 24 h after LPS inhalation were considerably higher
than in unexposed volunteers in the present study, and
similar data have been reported by others [23,37]. When
comparing the effect of infusion therapy on cytokine
generation a threefold increase in TNF-α concentration
in the SO group compared to the NaCl group after 8 h
and a 50 % reduction in IL-8 in the FO group compared
to this group after 24 h were visible. Most data available
on effects of n-3 and n-6 lipids point to a reduction in
inflammatory reactions by FO-derived lipids [9,18,32].
The finding of a pro-inflammatory effect of n-6 lipids
is more difficult to document [18,33].
Onset and persistence of the effect of lipid emulsions
The differential effect of lipid emulsions on isolated
monocytes or neutrophil cytokine generation required
pre-infusion and was measurable after only a two-day in-
fusion course and sustained up to 24 h after cessation of
the infusion, whereas the effect on adhesion and rolling
of monocytes was found at 8 h, but not at 24 h. This find-
ing is confirmed by the modulation of TNF-α and IL-8concentrations in the BALF by the lipid emulsions after 8
h or 24 h, respectively. In contrast to a previous study in
volunteers [18] where the effect of lipid emulsions was
observed in isolated monocytes 2 h after termination of
the infusion period, persistence of the effect of a short-
term 48-h infusion period for 24 h after termination of the
infusion was confirmed in the present study.
Impact of lipid emulsions on the inflammatory response
Infusion of conventional (SO) or FO-based lipid emul-
sions may not only regarded as a source of calories for
patients with a need for parenteral nutrition as these
lipid emulsions also modify the inflammatory response.
This is the first study in human volunteers to show that
after subsequent standardized LPS inhalation, the ability
of lipid emulsions to change adhesive properties of leu-
kocytes, including the generation of cytokines translating
into a modified invasion of leukocytes into the alveolar
space. After infusion of FO-based emulsions, recruited
neutrophils in the alveolar space were reduced. In con-
trast, rolling and adhesion of monocytes, and TNF-α
concentration in BALF were increased in the group re-
ceiving conventional (SO-based) lipid emulsions. Both
lipid emulsions differ only in the fatty acids supplied and
are used in many countries worldwide; however, both
may not be regarded as immune-neutral. It may be of
interest for the choice of lipid emulsions when consider-
ing parenteral infusions. Currently, the use of lipid emul-
sions rich in n-6 lipids is not encouraged by European
Guidelines [38]. This is in line with a recent Spanish
multicenter study demonstrating a higher infection rate
in critically ill patients receiving a standard lipid emul-
sion as compared to a lipid emulsion enriched with FO
[15]. For our study, we chose a pre-treatment strategy by
administration of lipid emulsions prior to induction of
pulmonary inflammation. This concept is of clinical rele-
vance as we might pre-treat/pre-condition patients with
an expected trauma (for example, operation) with lipid
emulsion to modulate an immune response. Thus far
there is a paucity of data investigating this concept in
terms of FO-based lipid emulsions and inflammation/
sepsis. Augmenting the line of our reasoning, a random-
ized controlled trial in surgical patients found that pre-
operative intravenous application of an FO-based lipid
emulsion modulated the post-operative immune re-
sponse [39].
The involvement of resolvins as a novel class of n-3
fatty acid derived lipid mediators might be responsible
for the different effects observed after infusion of FO or
SO in the context of ALI. This is the first study elucidat-
ing the impact of the resolvin E1 receptor ChemR23
on the pathogenesis of ARDS and lipid mediators.
ChemR23−/− mice show a diverse behavior compared
to WT controls, especially when challenged with FO,
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and deserves further investigation. Furthermore, the
difference between WT and ChemR23−/− mice is quite
striking and reinforces a role for the ChemR23-endo-
genous chemerin pathway in the modulation of the innate
immune response in vivo.
Conclusion
The present study extends previous observations in
demonstrating that a 48-h lipid infusion period suffices
to modify leukocyte adhesive properties as well as cyto-
kine generation and leukocyte invasion into the alveolar
space. This observation is of major interest as both lipid
emulsion employed in this investigation are approved for
parenteral nutrition in many countries. When consider-
ing parenteral nutrition in stable patients, for example,
before an operation, use of lipid emulsions enriched in
n-6 lipids does not seem to be beneficial. In fact, meta-
analysis of surgical patients and intensive care patients
undergoing parenteral nutrition supports the view that
including a small fraction of n-3 lipids into parenteral
regimes did reduce secondary infections and shortened
the length of stay [40,41]. The findings of this study
leave no doubt that in addition to fulfilling nutritional
functions, intravenous administration of lipid emulsions
has a strong impact on immunological functions and in-
flammatory processes in humans.
Key messages
 Lipid emulsion commercially available for clinical
use exerts different immunological effects on
alveaolar recruitment of leukocytes and generation
of cytokines in human volunteers
 FO-based lipid emulsions appear to reduce
alveolar recruitment of leukocytes and levels of
pro-inflammatory cytokines after LPS challenge.
 After infusion of SO-based lipid emulsions a
predominantly pro-inflammatory pattern is observed
 Beneficial effects of FO might at least in part be
mediated by resolvinE1 via ChemR23 receptorAdditional file
Additional file 1: Immunomodulation and lipid emulsions.
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